PubRank

Steven M Holland

Author PubWeight™ 393.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007 33.18
2 Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008 8.17
3 Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003 6.30
4 Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 2006 6.17
5 Phanerozoic trends in the global diversity of marine invertebrates. Science 2008 5.36
6 Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 2009 4.52
7 Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 2003 4.46
8 Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 2008 4.33
9 Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 2011 4.21
10 The research agenda of the National Institute of Allergy and Infectious Diseases for antimicrobial resistance. J Infect Dis 2008 3.84
11 Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010 3.83
12 Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002 3.23
13 Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 2009 3.13
14 JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 2013 3.07
15 Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood 2009 3.00
16 Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004 2.90
17 Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med 2012 2.87
18 Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 2007 2.85
19 GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 2013 2.82
20 Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004 2.80
21 Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 2010 2.61
22 Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J Clin Microbiol 2009 2.58
23 Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis 2008 2.55
24 Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med 2012 2.44
25 Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 2010 2.33
26 Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore) 2010 2.26
27 The hyper-IgE syndromes. Immunol Allergy Clin North Am 2008 2.19
28 X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med 2006 2.18
29 A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity 2011 2.15
30 Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J Biol Chem 2003 2.09
31 Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood 2011 2.08
32 Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med 2012 2.08
33 Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev 2005 2.07
34 Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol 2005 2.03
35 Nocardia veterana as a pathogen in North American patients. J Clin Microbiol 2003 2.03
36 Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 2004 2.01
37 Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet 2005 1.99
38 Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss. Sci Transl Med 2014 1.94
39 Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. Blood 2013 1.93
40 Hyper-IgE syndromes. Immunol Rev 2005 1.92
41 Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis 2009 1.91
42 Inborn errors of human JAKs and STATs. Immunity 2012 1.90
43 Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica 2011 1.89
44 Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 2003 1.86
45 Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex. J Infect Dis 2010 1.84
46 Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ Res 2007 1.77
47 Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Blood 2011 1.76
48 Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. Ann Am Thorac Soc 2014 1.76
49 Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J Infect Dis 2004 1.71
50 Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis 2010 1.70
51 Invasive aspergillosis due to Neosartorya udagawae. Clin Infect Dis 2009 1.70
52 NADPH oxidase limits innate immune responses in the lungs in mice. PLoS One 2010 1.69
53 Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection. Blood 2012 1.68
54 Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital. Clin Infect Dis 2008 1.67
55 A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease. PLoS Pathog 2006 1.66
56 Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun 2010 1.62
57 Nocardia infection in chronic granulomatous disease. Clin Infect Dis 2002 1.62
58 Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol 2007 1.61
59 Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen. Clin Infect Dis 2009 1.60
60 Role of NADPH oxidase in the mechanism of lung neutrophil sequestration and microvessel injury induced by Gram-negative sepsis: studies in p47phox-/- and gp91phox-/- mice. J Immunol 2002 1.60
61 A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3. Blood 2014 1.58
62 Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood 2010 1.56
63 Reinfection, rather than persistent infection, in patients with chronic granulomatous disease. J Infect Dis 2003 1.56
64 Loss of p47phox subunit enhances susceptibility to biomechanical stress and heart failure because of dysregulation of cortactin and actin filaments. Circ Res 2013 1.54
65 Nocardia kruczakiae sp. nov., a pathogen in immunocompromised patients and a member of the "N. nova complex". J Clin Microbiol 2004 1.54
66 NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem 2002 1.53
67 Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. Clin Infect Dis 2007 1.52
68 Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis. J Allergy Clin Immunol 2013 1.52
69 Corticosteroids in the treatment of severe nocardia pneumonia in chronic granulomatous disease. Pediatr Infect Dis J 2011 1.51
70 Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007. Chest 2012 1.50
71 Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 2004 1.50
72 Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol 2013 1.49
73 Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. J Clin Invest 2012 1.47
74 Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol 2011 1.46
75 Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis. J Immunol 2013 1.46
76 GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood 2013 1.44
77 Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis. J Clin Microbiol 2009 1.43
78 New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance. J Clin Microbiol 2013 1.43
79 In vivo lipid-derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model for ARDS. FASEB J 2002 1.42
80 Biallelic mutations in IRF8 impair human NK cell maturation and function. J Clin Invest 2016 1.39
81 Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models. Am J Pathol 2003 1.39
82 Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease. Clin Infect Dis 2011 1.39
83 Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function. J Immunol 2009 1.39
84 Serum free light chains as predictors of lymphomagenesis in patients with autosomal dominant hyper-immunoglobulin E syndrome (Job's syndrome). Leuk Lymphoma 2012 1.38
85 Clinical manifestations of hyper IgE syndromes. Dis Markers 2010 1.37
86 Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs. Respir Med 2009 1.36
87 Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr Res 2009 1.36
88 p47phox deficiency impairs NF-kappa B activation and host defense in Pseudomonas pneumonia. J Immunol 2004 1.36
89 Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol 2010 1.36
90 The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res 2013 1.35
91 Synaptic plasticity deficits and mild memory impairments in mouse models of chronic granulomatous disease. Mol Cell Biol 2006 1.35
92 Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest 2010 1.34
93 Thioglycollate peritonitis in mice lacking C5, 5-lipoxygenase, or p47(phox): complement, leukotrienes, and reactive oxidants in acute inflammation. J Leukoc Biol 2002 1.33
94 DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients. J Clin Immunol 2015 1.32
95 Hyper-IgE syndrome update. Ann N Y Acad Sci 2012 1.31
96 Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol 2013 1.31
97 Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis 2005 1.31
98 Highly variable clinical phenotypes of hypomorphic RAG1 mutations. Pediatrics 2010 1.30
99 Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease. Emerg Infect Dis 2010 1.27
100 Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. Clin Infect Dis 2010 1.25
101 Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis 2010 1.25
102 Determination of human anticytokine autoantibody profiles using a particle-based approach. J Clin Immunol 2011 1.25
103 Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clin Infect Dis 2005 1.24
104 Spatial clusters of nontuberculous mycobacterial lung disease in the United States. Am J Respir Crit Care Med 2012 1.24
105 Genome sequence analysis of the emerging human pathogenic acetic acid bacterium Granulibacter bethesdensis. J Bacteriol 2007 1.23
106 Acid aspiration-induced lung inflammation and injury are exacerbated in NADPH oxidase-deficient mice. Am J Physiol Lung Cell Mol Physiol 2006 1.22
107 Hepatic abscess in patients with chronic granulomatous disease. Ann Surg 2002 1.22
108 NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1. J Neurochem 2005 1.21
109 Persistent bacterial infections and primary immune disorders. Curr Opin Microbiol 2007 1.21
110 High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks. Emerg Infect Dis 2014 1.21
111 Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation. J Allergy Clin Immunol 2013 1.19
112 Anticytokine autoantibodies in infectious diseases: pathogenesis and mechanisms. Lancet Infect Dis 2010 1.18
113 Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency. Clin Infect Dis 2009 1.17
114 Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol 2004 1.17
115 Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review. Leuk Lymphoma 2004 1.17
116 Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica 2013 1.17
117 Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Res 2004 1.16
118 A microsatellite polymorphism in intron 2 of human Toll-like receptor 2 gene: functional implications and racial differences. FEMS Immunol Med Microbiol 2004 1.14
119 Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol 2011 1.14
120 Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management. Curr Opin Infect Dis 2012 1.14
121 The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. Free Radic Biol Med 2002 1.14
122 Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center. Clin Infect Dis 2009 1.14
123 Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin Immunol 2006 1.14
124 Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients. MBio 2014 1.12
125 A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J Immunol 2004 1.11
126 Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3. Curr Opin Allergy Clin Immunol 2008 1.10
127 Lung manifestations in an autopsy-based series of pulmonary or disseminated nontuberculous mycobacterial disease. Chest 2011 1.10
128 Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology 2007 1.10
129 Cognitive function in patients with chronic granulomatous disease: a preliminary report. Psychosomatics 2004 1.09
130 Interleukin-12 receptor β1 deficiency predisposing to disseminated Coccidioidomycosis. Clin Infect Dis 2011 1.09
131 Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey. J Pediatr 2004 1.09
132 Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1). Blood 2007 1.09
133 Immunodeficiency secondary to anticytokine autoantibodies. Curr Opin Allergy Clin Immunol 2010 1.08
134 MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature. Clin Infect Dis 2013 1.08
135 Granulibacter bethesdensis gen. nov., sp. nov., a distinctive pathogenic acetic acid bacterium in the family Acetobacteraceae. Int J Syst Evol Microbiol 2006 1.07
136 Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells. J Exp Med 2013 1.07
137 Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice. Antimicrob Agents Chemother 2002 1.07
138 Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology 2008 1.06
139 Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol 2012 1.06
140 Pathogenesis of hyper IgE syndrome. Clin Rev Allergy Immunol 2010 1.06
141 Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy. J Clin Endocrinol Metab 2005 1.05
142 Emericella quadrilineata as cause of invasive aspergillosis. Emerg Infect Dis 2008 1.05
143 Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol 2010 1.05
144 Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus. J Clin Invest 2013 1.05
145 Hematologically important mutations: leukocyte adhesion deficiency (first update). Blood Cells Mol Dis 2011 1.04
146 Decreased CD4+ lymphocytes and innate immune responses in adults with previous extrapulmonary tuberculosis. J Allergy Clin Immunol 2006 1.04
147 Familial clustering of pulmonary nontuberculous mycobacterial disease. Chest 2009 1.04
148 Pneumocystis jiroveci infection in patients with hyper-immunoglobulin E syndrome. Pediatrics 2006 1.04
149 Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics 2007 1.02
150 Corticosteroid therapy for liver abscess in chronic granulomatous disease. Clin Infect Dis 2011 1.02
151 The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases. Nat Rev Immunol 2013 1.02
152 Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit. Cardiovasc Res 2011 1.01
153 High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease. Clin Immunol 2010 1.01
154 Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome. J Allergy Clin Immunol 2009 1.01
155 Host susceptibility factors in mycobacterial infection. Genetics and body morphotype. Infect Dis Clin North Am 2002 1.00
156 Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy. J Clin Microbiol 2012 0.99
157 A novel connexin 26 gene mutation associated with features of the keratitis-ichthyosis-deafness syndrome and the follicular occlusion triad. J Am Acad Dermatol 2004 0.99
158 Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis. BMC Med Genet 2010 0.99
159 Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogen. Infect Immun 2011 0.97
160 Phagocyte NADPH oxidase, but not inducible nitric oxide synthase, is essential for early control of Burkholderia cepacia and chromobacterium violaceum infection in mice. Infect Immun 2003 0.97
161 What does the duty to warn require? Am J Bioeth 2013 0.97
162 Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum 2011 0.97
163 Adaptability and persistence of the emerging pathogen Bordetella petrii. PLoS One 2013 0.97
164 Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol 2013 0.96
165 Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival. J Allergy Clin Immunol 2013 0.96
166 Coronary artery abnormalities in Hyper-IgE syndrome. J Clin Immunol 2011 0.95
167 Rothia aeria neck abscess in a patient with chronic granulomatous disease: case report and brief review of the literature. J Clin Immunol 2012 0.95
168 Mycobacterium abscessus and M. avium trigger Toll-like receptor 2 and distinct cytokine response in human cells. Am J Respir Cell Mol Biol 2008 0.94
169 The role of surgery in the management of patients with refractory chronic granulomatous disease colitis. Dis Colon Rectum 2013 0.94
170 Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011. Emerg Infect Dis 2013 0.94
171 Immunotherapy for fungal infections. Clin Infect Dis 2006 0.93
172 Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia. J Virol 2007 0.93
173 A superoxide-hypersusceptible Salmonella enterica serovar Typhimurium mutant is attenuated but regains virulence in p47(phox-/-) mice. Infect Immun 2002 0.93
174 Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES). Clin Immunol 2011 0.93
175 Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism. J Allergy Clin Immunol 2013 0.92
176 "Mycobacterium tilburgii," a newly described, uncultivated opportunistic pathogen. J Clin Microbiol 2009 0.92
177 Extra-cellular superoxide promotes T cell expansion through inactivation of nitric oxide. J Neuroimmunol 2004 0.92
178 Persistent Mycobacterium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferon-gamma receptor-1 deficiency. Blood 2003 0.92
179 Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol 2004 0.92
180 Diagnostic assays for chronic granulomatous disease and other neutrophil disorders. Methods Mol Biol 2007 0.91
181 Chronic invasive aspergillosis caused by Aspergillus viridinutans. Emerg Infect Dis 2009 0.91
182 Abnormal nasal nitric oxide production, ciliary beat frequency, and Toll-like receptor response in pulmonary nontuberculous mycobacterial disease epithelium. Am J Respir Crit Care Med 2013 0.90
183 Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol 2011 0.90
184 Genomic insights into the emerging human pathogen Mycobacterium massiliense. J Bacteriol 2012 0.90
185 Hyper IgE syndrome: review and future directions. Expert Rev Clin Immunol 2005 0.90
186 Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. J Clin Invest 2015 0.90
187 Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease. Infect Immun 2009 0.90
188 Linezolid-resistant Staphylococcus aureus in two pediatric patients receiving low-dose linezolid therapy. Pediatr Infect Dis J 2006 0.90
189 Invasive infection with Trichosporon inkin in 2 siblings with chronic granulomatous disease. J Allergy Clin Immunol 2004 0.89
190 Draft Genome Sequences of Burkholderia cenocepacia ET12 Lineage Strains K56-2 and BC7. Genome Announc 2013 0.89
191 Anti-cytokine autoantibodies explain some chronic mucocutaneous candidiasis. Immunol Cell Biol 2010 0.89
192 High-dose continuous infusion beta-lactam antibiotics for the treatment of resistant Pseudomonas aeruginosa infections in immunocompromised patients. Ann Pharmacother 2010 0.89
193 Intrathoracic nontuberculous mycobacterial infections in otherwise healthy children. Pediatr Pulmonol 2009 0.88
194 Acidomonas methanolica-associated necrotizing lymphadenitis in a patient with chronic granulomatous disease. J Clin Immunol 2012 0.87
195 Invasive fungal infections in patients with chronic granulomatous disease. Adv Exp Med Biol 2013 0.87
196 Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease. Hum Mol Genet 2012 0.87
197 The first US domestic report of disseminated Mycobacterium avium complex and anti-interferon-γ autoantibodies. J Clin Immunol 2014 0.86
198 Spontaneous Staphylococcus xylosus infection in mice deficient in NADPH oxidase and comparison with other laboratory mouse strains. J Am Assoc Lab Anim Sci 2010 0.86
199 Hospitalizations associated with disseminated coccidioidomycosis, Arizona and California, USA. Emerg Infect Dis 2012 0.86
200 Mucormycosis in chronic granulomatous disease: association with iatrogenic immunosuppression. J Allergy Clin Immunol 2009 0.86
201 A familial syndrome of pulmonary nontuberculous mycobacteria infections. Am J Respir Crit Care Med 2013 0.86
202 Leukocyte adhesion deficiency in children and Irish setter dogs. Pediatr Res 2004 0.86
203 Skin ulcers and disseminated abscesses are characteristic of Serratia marcescens infection in older patients with chronic granulomatous disease. J Allergy Clin Immunol 2009 0.86
204 Human leukocytes kill Aspergillus nidulans by reactive oxygen species-independent mechanisms. Infect Immun 2010 0.86
205 Streptococcal infections in patients with chronic granulomatous disease: case report and review of the literature. J Clin Immunol 2012 0.85
206 Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association study. BMC Res Notes 2011 0.85
207 B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency. J Clin Immunol 2013 0.85
208 Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease. Antimicrob Agents Chemother 2006 0.85
209 Successful use of extracorporeal membrane oxygenation for acute respiratory failure in a patient with chronic granulomatous disease. J Pediatr Surg 2012 0.85
210 Coronary abnormalities in hyper-IgE recurrent infection syndrome: depiction at coronary MDCT angiography. AJR Am J Roentgenol 2009 0.85
211 Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency. Eur J Pediatr 2006 0.85
212 Yeast infections--human genetics on the rise. N Engl J Med 2009 0.84
213 Familial immunodeficiency with cutaneous vasculitis, myoclonus, and cognitive impairment. Am J Med Genet A 2004 0.84
214 Atypical presentation of IL-12 receptor beta1 deficiency with pneumococcal sepsis and disseminated nontuberculous mycobacterial infection in a 19-month-old girl born to nonconsanguineous US residents. J Allergy Clin Immunol 2009 0.84
215 Regarding "Trichosporon pullulans infection in 2 patients with chronic granulomatous disease". J Allergy Clin Immunol 2004 0.84
216 Antimicrobial prophylaxis for primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2009 0.83
217 Two cases illustrating successful adjunctive interferon-γ immunotherapy in refractory disseminated coccidioidomycosis. J Infect 2011 0.83
218 Complex regulation of human cathelicidin gene expression: novel splice variants and 5'UTR negative regulatory element. Mol Immunol 2007 0.83
219 Interferon-gamma receptor 1 promoter polymorphisms: population distribution and functional implications. Clin Immunol 2004 0.83
220 Draft genome sequence determination for cystic fibrosis and chronic granulomatous disease Burkholderia multivorans isolates. J Bacteriol 2012 0.83
221 Gastrointestinal fistulae in chronic granulomatous disease. Am J Gastroenterol 2009 0.83
222 WU polyomavirus in respiratory epithelial cells from lung transplant patient with Job syndrome. Emerg Infect Dis 2015 0.83
223 Serologic reactivity to the emerging pathogen Granulibacter bethesdensis. J Infect Dis 2012 0.83
224 GATA2 deficiency. Curr Opin Allergy Clin Immunol 2015 0.82
225 Diabetes, renal and cardiovascular disease in p47 phox-/- chronic granulomatous disease. J Clin Immunol 2013 0.82
226 Correlating interleukin-12 stimulated interferon-γ production and the absence of ectodermal dysplasia and anhidrosis (EDA) in patients with mutations in NF-κB essential modulator (NEMO). J Clin Immunol 2014 0.82
227 Congenital defects in the interferon-gamma/interleukin-12 pathway. Curr Opin Pediatr 2004 0.82
228 Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome. J Clin Immunol 2013 0.81
229 CARD9: at the intersection of mucosal and systemic antifungal immunity. Blood 2013 0.81
230 The use of 14C-FIAU to predict bacterial thymidine kinase presence: implications for radiolabeled FIAU bacterial imaging. Nucl Med Biol 2013 0.80
231 Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination. Pediatrics 2007 0.80
232 Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations. Cancer Med 2015 0.80
233 Characterization of a dipeptide motif regulating IFN-gamma receptor 2 plasma membrane accumulation and IFN-gamma responsiveness. J Immunol 2004 0.80
234 Recent insights into the pathobiology of innate immune deficiencies. Curr Allergy Asthma Rep 2011 0.80
235 Recurrent Burkholderia gladioli suppurative lymphadenitis associated with neutralizing anti-IL-12p70 autoantibodies. J Clin Immunol 2013 0.79
236 Fever and leg pain in a 42-month-old. Ann Allergy Asthma Immunol 2002 0.79
237 Legionella feeleii serotype 2 pneumonia in a man with chronic lymphocytic leukemia: a challenging diagnosis. J Clin Microbiol 2010 0.79
238 Disseminated trichosporonosis in a murine model of chronic granulomatous disease. Comp Med 2003 0.79
239 Variable presentation of disseminated nontuberculous mycobacterial infections in a family with an interferon-gamma receptor mutation. Clin Infect Dis 2004 0.78
240 NADPH-oxidase-driven oxygen radical production determines chondrocyte death and partly regulates metalloproteinase-mediated cartilage matrix degradation during interferon-gamma-stimulated immune complex arthritis. Arthritis Res Ther 2005 0.78
241 White blood cell defects: molecular discoveries and clinical management. Curr Allergy Asthma Rep 2002 0.78
242 Bone density and fractures in autosomal dominant hyper IgE syndrome. J Clin Immunol 2014 0.78
243 Altered antibody profiles against common infectious agents in chronic disease. PLoS One 2013 0.78
244 Methylotroph Infections and Chronic Granulomatous Disease. Emerg Infect Dis 2016 0.77
245 Diagnostic assays for chronic granulomatous disease and other neutrophil disorders. Methods Mol Biol 2014 0.77
246 Acupuncture for symptom management in patients with hyper-IgE (Job's) syndrome. J Altern Complement Med 2011 0.77
247 Chronic granulomatous disease. Inflamm Bowel Dis 2010 0.77
248 B-cell activating factor (BAFF) is elevated in chronic granulomatous disease. Clin Immunol 2013 0.77
249 Hepatoportal venopathy due to disseminated Mycobacterium avium complex infection in a child with IFN-gamma receptor 2 deficiency. Virchows Arch 2007 0.77
250 CD40 ligand deficiency: neurologic sequelae with radiographic correlation. Pediatr Neurol 2009 0.77
251 A novel internalization motif regulates human IFN-γ R1 endocytosis. J Leukoc Biol 2012 0.77
252 Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. J Clin Invest 2016 0.76
253 Safety of major abdominal surgical procedures in patients with hyperimmunoglobulinemia E (Job's syndrome): a changing paradigm? J Gastrointest Surg 2012 0.76
254 Auditory and vestibular phenotypes associated with GATA3 mutation. Otol Neurotol 2014 0.76
255 IL2RG reversion event in a common lymphoid progenitor leads to delayed diagnosis and milder phenotype. J Clin Immunol 2015 0.75
256 MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections. JCI Insight 2017 0.75
257 Risk Factors for Disseminated Coccidioidomycosis, United States. Emerg Infect Dis 2017 0.75
258 Evolution: A history of give and take. Nature 2013 0.75
259 Twenty-year follow-up of esophageal involvement in chronic granulomatous disease. Am J Gastroenterol 2009 0.75
260 Molecular identification of bacterial DNA in the chorioretinal scars of chronic granulomatous disease. J Clin Immunol 2013 0.75
261 Prostatic abscess in a pediatric patient with chronic granulomatous disease: report of a unique case and review of the literature. J Pediatr Surg 2012 0.75
262 Evolution of an intronic microsatellite polymorphism in Toll-like receptor 2 among primates. Immunogenetics 2006 0.75
263 Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease. Inflamm Bowel Dis 2016 0.75
264 Streptococcal infections in patients with chronic granulomatous disease: case report and review of the literature. J Clin Immunol 2012 0.75
265 Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma. MAbs 2014 0.75
266 More on "Eurekapenia". Pharos Alpha Omega Alpha Honor Med Soc 2004 0.75
267 Immunomodulation. Curr Opin Pharmacol 2002 0.75
268 When to leave a stone unturned ... Gut 2010 0.75
269 Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease. Inflamm Bowel Dis 2016 0.75
270 A man with distinctive facial features and recurrent pyoderma, pneumonia, and skeletal fractures. J Am Acad Dermatol 2004 0.75
271 GI involvement in disseminated Mycobacterium genavense: endoscopy and histology. Gastrointest Endosc 2011 0.75
272 Percutaneous vertebroplasty as a palliative measure in the setting of chronic infection. J Pain Symptom Manage 2006 0.75
273 Correction: Self-reactive VH4-34-expressing IgG B cells recognize commensal bacteria. J Exp Med 2017 0.75
274 Case series: biliary leak after transjugular liver biopsy. Am J Gastroenterol 2013 0.75
275 A 5-week-old HIV-1-exposed girl with failure to thrive and diffuse nodular pulmonary infiltrates. J Allergy Clin Immunol 2004 0.75
276 Neurobehavioral profiles in individuals with hyperimmunoglobulin E Syndrome (HIES) and brain white matter hyperintensities. J Clin Immunol 2013 0.75